Patients who need PCSK9 inhibitors can’t get them April 29, 2017By Tracey WalkerStudy: PCSK9 inhibitors are being rejected by insurers at very high rates even in high-risk patients like those with familial hypercholesterolemia. How one hospital reduced pediatric epilepsy emergency visits, admissions April 18, 2017By Tracey WalkerNationwide Children’s Hospital sees dramatic drop in ED visits and inpatient admissions for epilepsy patients with collaborative quality improvement project. Game-changing cholesterol-buster further reduces heart attack, stroke April 16, 2017By Tracey WalkerA new outcomes study shows that the PCSK9 inhibitor Repatha significantly reduced the risk of hard major adverse cardiovascular events in high-risk patients by 20%. Four steps managed care can take to promote antimicrobial stewardshipThe call for antimicrobial stewardship is growing. Enact these steps to prevent a return to the pre-antibiotic era. Prescribing practices that increase risk of opioid overdose April 11, 2017By Tracey WalkerTwo studies, one from Prime Therapeutics and Stanford, reveal an alarming increase in overdose with concurrent use of opioids and benzodiazepines. Here’s how managed care can help. Insulin treatment persistence varies among payers March 25, 2017By Tracey WalkerA study from Walgreens provides a benchmark of basal insulin treatment persistence across different payers in the United States. How to target high-risk populations with behavioral health March 23, 2017By Ron Geraty MDHere are four of the top benefits of incorporating behavioral health management into care management plans for members with chronic conditions. Inaccurate provider directories create barriers to careHere are four ways that health plans can improve their internal processes for collecting provider data. Payers to pharma: Here’s what we’re missing in hep C drugs February 17, 2017By Tracey WalkerA Precision for Value survey highlights what can be done in order to encourage payers to ease coverage policies for these drugs in the next wave of HCV treatment. Seven ways the blocked Aetna-Humana merger affects the industry January 25, 2017By Tracey WalkerThe proposed megamerger has been shot down. Find out what it means for healthcare execs.